(1) Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan;(2) Cardiovascular Research Institute, University of California San Francisco, Box 0130, 94143 San Francisco, CA, USA
Abstract:
A 65-year-old man developed severe septic shock during thrombolytic treatment with urokinase for pulmonary thromboembolism associated with deep venous thrombosis of the right lower limb. Blood cultures were positive forKlebsiella pneumoniae and treatment was successful only when the antibiotics were infused via the same route as the urokinase.